CRT 2025
Spotlight
Radiation Protection
James A. Goldstein, MD, FSCAI
Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States
Disclosure(s): ECLS Inc Licensee of Radiation Protection technology to Image Diagnostics Inc Fitchberg Mass: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
James B. Hermiller, MD, FACC, MSCAI
Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States
Disclosure(s): Abbott Vascular, Edwards: Consultant (Ongoing)
David G. Rizik, MD, MSCAI, FACC
Chief Scientific Officer, Chief of Complex Interventional Cardiology, Director of Structural & Coronary Intervention, Interventional Cardiology Fellowship Program Director
HonorHealth, Scottsdale Arizona
Scottsdale, Arizona, United States
Disclosure(s): No financial relationships to disclose
Ryan D. Madder, MD
Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes;
Director of Interventional Cardiovascular Research and Clinical Trials;
Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States
Disclosure(s): Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)